Skip to main content Back to Top
Advertisement

3/30/2024

Oxycodone Hydrochloride and Acetaminophen Tablets

Products Affected - Description

    • Oxycodone hydrochloride and Acetaminophen oral tablet, Amneal, 7.5 mg / 325 mg, bottle, 100 count, NDC 65162-0207-10
    • Oxycodone hydrochloride and Acetaminophen oral tablet, Camber, 10 mg / 325 mg, bottle, 100 count, NDC 31722-0951-01 - discontinued
    • Oxycodone hydrochloride and Acetaminophen oral tablet, Camber, 10 mg / 325 mg, bottle, 500 count, NDC 31722-0951-05 - discontinued
    • Oxycodone hydrochloride and Acetaminophen oral tablet, Camber, 2.5 mg / 325 mg, bottle, 100 count, NDC 31722-0948-01 - discontinued
    • Oxycodone hydrochloride and Acetaminophen oral tablet, Camber, 5 mg / 325 mg, bottle, 100 count, NDC 31722-0949-01 - discontinued
    • Oxycodone hydrochloride and Acetaminophen oral tablet, Camber, 5 mg / 325 mg, bottle, 500 count, NDC 31722-0949-05 - discontinued
    • Oxycodone hydrochloride and Acetaminophen oral tablet, Camber, 7.5 mg / 325 mg, bottle, 100 count, NDC 31722-0950-01 - discontinued
    • Oxycodone hydrochloride and Acetaminophen oral tablet, Camber, 7.5 mg / 325 mg, bottle, 500 count, NDC 31722-0950-05 - discontinued
    • Oxycodone hydrochloride and Acetaminophen oral tablet, KVK-Tech, 10 mg / 325 mg, bottle, 100 count, NDC 10702-0187-01
    • Oxycodone hydrochloride and Acetaminophen oral tablet, KVK-Tech, 10 mg / 325 mg, bottle, 500 count, NDC 10702-0187-50
    • Oxycodone hydrochloride and Acetaminophen oral tablet, KVK-Tech, 5 mg / 325 mg, bottle, 100 count, NDC 10702-0185-01
    • Oxycodone hydrochloride and Acetaminophen oral tablet, KVK-Tech, 5 mg / 325 mg, bottle, 500 count, NDC 10702-0185-50
    • Oxycodone hydrochloride and Acetaminophen oral tablet, KVK-Tech, 7.5 mg / 325 mg, bottle, 100 count, NDC 10702-0186-01
    • Oxycodone hydrochloride and Acetaminophen oral tablet, KVK-Tech, 7.5 mg / 325 mg, bottle, 500 count, NDC 10702-0186-50 - discontinued
    • Oxycodone hydrochloride and Acetaminophen oral tablet, Major, 10 mg / 325 mg, unit-dose blister pack, 100 count, NDC 00904-7095-61
    • Oxycodone hydrochloride and Acetaminophen oral tablet, Major, 5 mg / 325 mg, unit-dose blister pack, 100 count, NDC 00904-7093-61
    • Oxycodone hydrochloride and Acetaminophen oral tablet, Major, 7.5 mg / 325 mg, unit-dose blister pack, 100 count, NDC 00904-7094-61

Reason for the Shortage

    • Amneal did not provide a reason for the shortage.
    • Camber discontinued their oxycodone and acetaminophen presentations.
    • Endo has Percocet available.
    • KVK-Tech is awaiting DEA quota approval for active ingredient.
    • Major did not provide a reason for the shortage.
    • Mallinckrodt was not available to provide information.
    • Par has Endocet available.
    • Rhodes oxycodone and acetaminophen presentations available.

Available Products

    • Endocet oral tablet, Par Pharmaceuticals, 10 mg / 325 mg, bottle, 100 count, NDC 60951-0712-70
    • Endocet oral tablet, Par Pharmaceuticals, 2.5 mg / 325 mg, bottle, 100 count, NDC 60951-0701-70
    • Endocet oral tablet, Par Pharmaceuticals, 5 mg / 325 mg, bottle, 100 count, NDC 60951-0602-70
    • Endocet oral tablet, Par Pharmaceuticals, 5 mg / 325 mg, bottle, 500 count, NDC 60951-0602-85
    • Endocet oral tablet, Par Pharmaceuticals, 7.5 mg / 325 mg, bottle, 100 count, NDC 60951-0700-70
    • Percocet oral tablet, Endo Pharmaceuticals, 10 mg / 325 mg, bottle, 100 count, NDC 63481-0629-70
    • Percocet oral tablet, Endo Pharmaceuticals, 2.5 mg / 325 mg, bottle, 100 count, NDC 63481-0627-70
    • Percocet oral tablet, Endo Pharmaceuticals, 5 mg / 325 mg, bottle, 100 count, NDC 63481-0623-70
    • Percocet oral tablet, Endo Pharmaceuticals, 5 mg / 325 mg, bottle, 500 count, NDC 63481-0623-85
    • Percocet oral tablet, Endo Pharmaceuticals, 7.5 mg / 325 mg, bottle, 100 count, NDC 63481-0628-70
    • Oxycodone hydrochloride and Acetaminophen oral tablet, Amneal, 10 mg / 325 mg, bottle, 100 count, NDC 53746-0204-01
    • Oxycodone hydrochloride and Acetaminophen oral tablet, Amneal, 10 mg / 325 mg, bottle, 500 count, NDC 53746-0204-05
    • Oxycodone hydrochloride and Acetaminophen oral tablet, Amneal, 5 mg / 325 mg, bottle, 100 count, NDC 53746-0203-01
    • Oxycodone hydrochloride and Acetaminophen oral tablet, Amneal, 5 mg / 325 mg, bottle, 500 count, NDC 53746-0203-05
    • Oxycodone hydrochloride and Acetaminophen oral tablet, Amneal, 7.5 mg / 325 mg, bottle, 500 count, NDC 65162-0207-50
    • Oxycodone hydrochloride and Acetaminophen oral tablet, KVK-Tech, 2.5 mg / 325 mg, bottle, 100 count, NDC 10702-0184-01
    • Oxycodone hydrochloride and Acetaminophen oral tablet, Rhodes, 10 mg / 325 mg, bottle, 100 count, NDC 42858-0104-01
    • Oxycodone hydrochloride and Acetaminophen oral tablet, Rhodes, 10 mg / 325 mg, bottle, 500 count, NDC 42858-0104-50
    • Oxycodone hydrochloride and Acetaminophen oral tablet, Rhodes, 5 mg / 325 mg, bottle, 100 count, NDC 42858-0102-01
    • Oxycodone hydrochloride and Acetaminophen oral tablet, Rhodes, 5 mg / 325 mg, bottle, 500 count, NDC 42858-0102-50
    • Oxycodone hydrochloride and Acetaminophen oral tablet, Rhodes, 7.5 mg / 325 mg, bottle, 100 count, NDC 42858-0103-01
    • Oxycodone hydrochloride and Acetaminophen oral tablet, Rhodes, 7.5 mg / 325 mg, bottle, 500 count, NDC 42858-0103-50

Estimated Resupply Dates

    • Amneal has oxycodone and acetaminophen 7.5 mg / 325 mg tablets in 100 count bottles on back order and the company cannot estimate a release date.
    • KVK-Tech has oxycodone and acetaminophen 10 mg / 325 mg tablets in 100 count and 500 count bottles on back order and the company cannot estimate a release date. The 5 mg / 325 mg in the 100 count and 500 count bottles and 7.5 mg / 325 mg tablets in 100 count bottles are on long-term back order and the company cannot estimate a release date.
    • Major has oxycodone and acetaminophen 5 mg / 325 mg tablets, 7.5 mg / 325 mg tablets, and 10 mg / 325 mg in 100 count unit-dose packages on back order and the company cannot estimate a release date.

Updated

Updated March 30, 2024 by Elyse MacDonald, PharmD, MS, BCPS. Created July 19, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.
ADVERTISEMENT